Objective To evaluate the long‐term seizure outcome and potential factors associated with
seizure outcome in patients with anti‐N‐methyl‐d‐aspartate receptor (anti‐NMDAR) …

Background We identified seizure characteristics, long-term outcome, and predictors of
persistent seizures in children with anti-N-methyl-d-aspartate receptor (anti-NMDAR) …

Objective: The clinical characteristics of patients with relapsing anti–NMDA receptor
(NMDAR) encephalitis are not well-defined. In this study, we report the clinical profile and …

Importance Patients with anti–N-methyl-d-aspartate receptor (NMDAR) encephalitis often
develop prominent psychiatric manifestations. The frequency and type of isolated psychiatric …

Background and purpose Data concerning the characteristics and duration of the critical
manifestations, treatment response, and long-term outcomes of severe anti-N-methyl-d …

Background and purpose The aim was to analyse the clinical profiles and outcomes of
patients with anti‐N‐methyl‐d‐aspartate receptor (anti‐NMDAR) encephalitis in China …

Objectives We aimed to (i) analyse the clinical characteristics, treatment outcome and long-
term prognosis of anti-NMDAR encephalitis and (ii) study the differences between paediatric …

Objective Seizures develop in 80% of patients with anti–N‐methyl‐d‐aspartate receptor
(NMDAR) encephalitis, and these represent a major cause of morbidity and mortality. Anti …

Objective: Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is the most
common form of autoimmune encephalitis in pediatric patients. In this study, we aimed to …

Objective Anti‐N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis is a severe
autoimmune disorder with a mortality of 5%‐7%, but few studies have focused on the …